It is noteworthy that the suppressive effects on NF-kB signaling have been validated when the IKK inhibition by BAs has been studied in the CD18 hypomorphic (CD18[hypo]) mouse model of psoriasis, suggesting that targeting NF-kB with BAs may be an effective strategy (Wang et al. 2009). Here, NFKB1 is linked to psoriasis.